CRISPR proteins lead to novel POC diagnostics
February 10, 2020 -- A novel tool that detects the presence of specific nucleic acid sequences is the basis for a new family of point-of-care (POC) diagnostics, which could take the form of an at-home test strip in the next few years.  Discuss
Lumos gets cash to expand reach of respiratory test
February 6, 2020 -- Lumos Diagnostics has received $1.5 million in series A funding from parent company Planet Innovation of Box Hill, Victoria, Australia.
Drawbridge's POC HbA1c test cleared for Europe
February 4, 2020 -- The OneDraw single-use, point-of-care (POC) test for hemoglobin A1c (HbA1c) has the CE Mark for sale in European markets, according to its developer, Drawbridge Health, a private company founded by General Electric.
Barbershop POC blood tests pick up undiagnosed diabetes
January 27, 2020 -- Barbershops are good places for on-the-spot testing of black men for hemoglobin A1c, according to a study published January 27 in JAMA Internal Medicine. One-third of men approached agreed to point-of-care (POC) blood testing, and of those, 9% had undiagnosed diabetes.  Discuss
Point-of-care test for lethal spotted fever infections in the pipeline
January 21, 2020 -- Researchers have identified a biomarker and developed a blood test for the tick-borne Mediterranean spotted fever and other rickettsial infections, with the hope of greatly improving upon the standard of care, according to a small study published online January 16 in the American Journal of Pathology.  Discuss
Sphingotec launches penKid kidney function blood test
January 16, 2020 -- German IVD developer Sphingotec is making its penKid point-of-care biomarker blood test for evaluating kidney function available at the end of this month in countries that recognize the CE Mark.
Dexcom, Livongo partner on glucose monitoring
January 13, 2020 -- Dexcom is set to synchronize data collected using its G6 continuous glucose monitoring product into Livongo's applied health signals platform, per an agreement announced on January 13, the first day of the annual J.P. Morgan Healthcare Conference in San Francisco.
Inflammatix gets $32M infusion for HostDx rapid POC tests
January 10, 2020 -- California startup Inflammatix has raised $32 million in series C financing, which it plans to use to move its HostDx rapid point-of-care (POC) tests for acute infection and sepsis through registration in the U.S. and commercial launch in Europe by 2021.
Top 10 product news stories for 2019
December 24, 2019 -- There were hundreds of developments in IVD testing in 2019, so selecting just 10 is a huge challenge. But Bruce Carlson, publisher of market research firm Kalorama Information, has picked out the highlights for you.  Discuss
Top 10 LabPulse stories for 2019
December 23, 2019 -- Automation, artificial intelligence (AI), and utilization management were hot topics in lab medicine in 2019, at least according to the articles that were most viewed by members of for the year. In fact, three out of the top five most-read stories revolved around automation and AI.  Discuss